Janus Henderson Group’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-44,526	Closed	-$67.5K	–	2636
2023 Q1	$67.5K	Buy	44,526 +26,787	+151%	+$67.1K	﹤0.01%	2644
2022 Q4	$44.3K	Sell	17,739 -17,735	-50%	-$57.1K	﹤0.01%	2423
2022 Q3	$150K	Buy	35,474 +17,783	+101%	+$69.6K	﹤0.01%	2451
2022 Q2	$50K	Sell	17,691 -39	-0.2%	-$157	﹤0.01%	2554
2022 Q1	$102K	Buy	+17,730	New	+$130K	﹤0.01%	2556
2020 Q4	–	Sell	-464,301	Closed	-$6.88M	–	1404
2020 Q3	$6.88M	Sell	464,301 -216,454	-32%	-$3.38M	﹤0.01%	879
2020 Q2	$10M	Sell	680,755 -2,489,265	-79%	-$40.9M	0.01%	805
2020 Q1	$37.2M	Sell	3,170,020 -1,745,293	-36%	-$32.8M	0.03%	526
2019 Q4	$116M	Sell	4,915,313 -214,028	-4%	-$4.74M	0.06%	326
2019 Q3	$94.9M	Buy	5,129,341 +19,617	+0.4%	+$361K	0.05%	385
2019 Q2	$95M	Sell	5,109,724 -87,951	-2%	-$1.76M	0.05%	389
2019 Q1	$127M	Sell	5,197,675 -239,865	-4%	-$6.28M	0.07%	319
2018 Q4	$141M	Buy	5,437,540 +10,549	+0.2%	+$290K	0.09%	272
2018 Q3	$172M	Sell	5,426,991 -443,819	-8%	-$16.5M	0.09%	261
2018 Q2	$228M	Sell	5,870,810 -2,150,540	-27%	-$68.5M	0.13%	203
2018 Q1	$221M	Buy	8,021,350 +959,488	+14%	+$21.8M	0.13%	198
2017 Q4	$128M	Buy	7,061,862 +1,294,367	+22%	+$21.1M	0.08%	308
2017 Q3	$93.1M	Buy	5,767,495 +126,039	+2%	+$1.98M	0.06%	380
2017 Q2	$78.1M	Buy	+5,641,456	New	+$81.7M	0.05%	408